The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells-Reference-Cited by-同舟云学术

The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells

Published:2019-08-12 Issue:42 Volume:38 Page:6801-6817
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Gobbi Giulia,Donati Benedetta,Do Valle Italo Faria,Reggiani Francesca,Torricelli Federica,Remondini Daniel,Castellani Gastone,Ambrosetti Davide Carlo,Ciarrocchi Alessia,Sancisi Valentina^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-019-0924-1.pdf

Reference50 articles.

1. Zaman A, Bivona TG. Emerging application of genomics-guided therapeutics in personalized lung cancer treatment. Ann Transl Med. 2018;6:160.

2. Kanno T, Kanno Y, LeRoy G, Campos E, Sun HW, Brooks SR, et al. BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones. Nat Struct Mol Biol. 2014;21:1047–57.

3. Dawson MA, Prinjha RK, Dittmann A, Giotopoulos G, Bantscheff M, Chan WI, et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature. 2011;478:529–33.

4. Lockwood WW, Zejnullahu K, Bradner JE, Varmus H. Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins. Proc Natl Acad Sci USA. 2012;109:19408–13.

5. Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153:320–34.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on anti-tumor mechanism of TAOK kinases;Cellular Signalling;2024-09

2. BET inhibition revealed varying MYC addiction mechanisms independent of gene alterations in aggressive B-cell lymphomas.;2024-07-22

3. BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3;Nature Communications;2024-03-22

4. The golden key to open mystery boxes of SMARCA4-deficient undifferentiated thoracic tumor: focusing immunotherapy, tumor microenvironment and epigenetic regulation;Cancer Gene Therapy;2024-02-13

5. CRISPR screening identifies BET and mTOR inhibitor synergy in cholangiocarcinoma through serine glycine one carbon;JCI Insight;2024-01-23